12:00 AM
Aug 06, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

DexaSite dexamethasone: Phase III delayed

InSite said in its 2Q12 earnings that it will delay until further notice the start of a Phase III trial to evaluate DexaSite to save cash and focus on ongoing Phase III DOUBle trial to treat blepharitis and clinical trials of BromSite. Details were...

Read the full 208 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >